Ventracor
Jump to navigation
Jump to search
Ventracor Limited (VCR) "is primarily involved in the development of the 'VentrAssist' ventricular assist device for the management of end-stage congestive heart failure. VCR gained European approval in Dec-06, allowing the commencement of commercial sales in Europe in early CY07. The same device is still currently navigating its way through a US feasibility study as VCR works towards gaining FDA approval for VentrAssist." [1]
- Peter A. Crosby, CEO
- Graeme Fallet, Chief Financial Officer
Directors
Accessed November 2008: [2]
- Elizabeth Nosworthy Director
- John Ward Chairman
- Ross Harricks Director
- Katherine Woodthorpe
- John Goodman Non-Executive Director
- Colin Sutton PhD - Managing Director and CEO
- John Massey
